Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsemari, Muhannad A., Hakeam, Hakeam A., Alsalman, Hussain, Amin, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453436/
https://www.ncbi.nlm.nih.gov/pubmed/32922782
http://dx.doi.org/10.1177/2049936120952605
Descripción
Sumario:High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation within 48 h of receiving high-dose tigecycline.

Ejemplares similares